They duly cleared the ground over what had been the ancient church and made a stunning discovery: Underneath the rubble was a huge mosaic of a detailed map. Although damaged in places, its myriad ...

Mining giant Mosaic requested to use phosphogypsum to build a test road at its Mulberry site on March 31, 2022. The EPA reviewed the plan, gave notice of pending approval on Oct. 9 of last year ...

A 1,600-year-old Byzantine-era mosaic from a Christian monastery was recently put on public display for the first time, giving a glimpse into life during ancient times. The Israeli Ministry of ...

As we say farewell to one of Manchester City's greatest-ever players, Kevin De Bruyne, we're inviting fans to mark his final match at the Etihad by creating their very own King Kev mosaic! This unique ...

EXCLUSIVE: Mosaic has signed for management Matt Berry, the Emmy-nominated, BAFTA-winning actor, writer and musician best known for his work on Taika Waititi’s FX series What We Do in the Shadows.

Mosaic's vertical integration and diverse product portfolio, including phosphorous and potash fertilizers, enable cost control and market flexibility, ensuring resilience amid industry ...

Mosaic Youth Theatre of Detroit is bringing Shakespeare’s “Julius Caesar” to the D — quite literally. The theatre is reimagining the classic play in modern times, set in a Detroit high ...

Mosaic (MOS) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.65 per share a year ago. These figures ...

TAMPA, FL / ACCESS Newswire / May 6, 2025 / The Mosaic Company (NYSE:MOS) released its financial results for the first quarter of 2025. The company's earnings release and supplemental materials ...

Mosaic Therapeutics a UK-based oncology company has announced it has in-licensed two clinical-stage oncology programmes from Astex Pharmaceuticals. The agreement transforms Mosaic from a ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex Pharmaceuticals. The small ...

In-licensing these clinical-stage assets has significantly de-risked and accelerated Mosaic’s development path; the compounds will be developed as proprietary combination therapies Syncona Ltd, ...